Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
57 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2026
Farmaceutica from Leuven, company number BE0473789966, closed financial year 2026 with a result of € -473 after tax. For that financial year Farmaceutica recorded revenue of € 181,804 and equity of € 183,651. Compared with financial year 2025, the result moved from € 2,544 to € -473. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 17, 2026.
€ 183,651
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -473
▼ still € 2,544 profit in 2025
Profit after tax over the fiscal year.
€ 178,087
▲ 5% vs 2025
Cash and bank balances on the last day of the fiscal year.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 295
▼ 81% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 188
▼ 32% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Revenue | € 145,476 | € 174,527 | € 162,242 | € 181,804 | ▲ 12% |
| Gross margin | € 11,812 | € 15,543 | € 14,355 | € -643 | ▼ € 14,997 |
| Profit after taxes | € 11,734 | € 15,925 | € 2,544 | € -473 | ▼ € 3,017 |
| Equity | € 165,655 | € 181,580 | € 184,125 | € 183,651 | |
| Total debts | € 3,490 | € 3,820 | € 1,835 | € 483 | ▼ 74% |
| Cash | € 154,359 | € 153,956 | € 169,538 | € 178,087 | ▲ 5% |
| Retained profit | € 103,356 | € 119,282 | € 121,826 | € 121,353 | |
| Balance sheet total | € 169,145 | € 185,400 | € 185,960 | € 184,135 | ▼ 1% |
Key figures of Farmaceutica, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 30 January 2028.
What happened to Farmaceutica?
What happened at Farmaceutica in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: loss of € 473 (▼ € 3,017 vs 2025). Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 11,734 profit in 2023 to € 473 loss in 2026.
Paid € 1,838 in corporate taxes since 2023.
Best year ever: 2024, with € 15,925 profit.
Management
Behind Farmaceutica are Vincent Jennes, Tom Buschop and Sem Drummen.
Directors
According to the 2026 annual accounts
Vincent Jennes
Vice-chairman of the board
Tom Buschop
Penningmeester
Sem Drummen
Chairman of the board
Establishments
Establishment units
Physical locations of this company
Herestraat 49 box 423
3000 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 57 companies are registered at this address.
All companies at this address →The Association for European Paediatric and Congenital Cardiology
Stfran.
€ 75,987 revenue · 2023
ALFAGEN: Alumni van de FAculteit GENeeskunde KU Leuven
Rega Instituut
€ -7,459 gross margin · 2025
Vlaamse Vereniging voor Seksuologie
+52 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0473.789.966
- VAT number
- BE 0473.789.966
- Registered office
- Herestraat 49 bus 423, 3000 Leuven
- Names & denominations
- Farmaceutica
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 21 November 2000
- Peppol
- Active · Active since 16 Dec 2025
- Activities · NACE
Overige persoonlijke diensten